Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages
Filter by Categories
Analysis
Comment
Deals
Events
News
People

$100m-$499m

Legend Biotech lands $151m
Lilly Asia Ventures and Johnson & Johnson Innovation – JJDC are both investing in a series A round for the cell therapy developer, a spinoff from Genscript Biotech.
AM-Pharma amplifies latest round to $182m
Cowen and European Investment Bank added $52m to a $130m first tranche closed by the AbbVie and Pfizer-backed kidney injury drug developer in July.
6 Dimensions supports $125m round for iTeos
The WuXi-backed investment firm returned for a series B2 round that will support phase 1/2 trials for iTeos Therapeutics' oncology therapies.
Collibra collects $112m
CapitalG returned for a late-stage round that pushed Collibra’s total funding beyond $345m and boosted its valuation to $2.3bn.
4Paradigm fixes $230m in funding
Cisco and Lenovo helped the artificial intelligence software producer hike its valuation from $1.2bn to $2bn, following a $145m round in 2018.
Ozon gets in the zone with $150m
Sistema has participated in a $150m financing round for e-commerce platform developer Ozon having acquired the stake held by fellow corporate MTS last year.
Hualan Biological Vaccines hooks $292m
Hillhouse Capital and Chen Yi Investment are making a secondary investment in the Hualan Biological Engineering spinoff which is now valued at more than $1.9bn.
Exor mobilises $200m for Via Transportation
Transportation services provider Via raised the money as part of a series E round also featuring Shell, Hearst Ventures and Mori Building valuing it at $2.25bn.

Other News

GSK displays Lyell Immunopharma investment
The corporate owned a 15% stake in immunotherapy developer Lyell, which recently raised $493m, with a fair value of $203m as of the end of 2019.
Plenty prepares to raise $100m
The indoor farm operator, which has already raised $400m, is in talks with existing investor SoftBank Vision Fund for a round likely to value it at up to $1bn.
Analysis: Two new deals in mobility last week
Amid a nearly global lockdown and much apprehension around the Covid-19 pandemic, we reported two interesting deals in the mobility space last week.
MiningLamp ramps up with $300m
The big data technology provider increased its overall funding to $786m in a Tencent-led round that also featured fellow corporate Kuaishou.
SutroVax sorts out $110m series D
Roche Venture Fund returned to help SutroVax, a developer of vaccines for a range of deadly infectious diseases, push its overall funding past $280m.
Kallyope digests $112m in series C round
Illumina Ventures was among the returning investors for the round that will help Kallyope prepare a weight loss treatment for clinical trials.

Editor's Picks

Exor mobilises $200m for Via Transportation
Transportation services provider Via raised the money as part of a series E round also featuring Shell, Hearst Ventures and Mori Building valuing it at $2.25bn.
Letgo links to OfferUp in merger deal
Naspers subsidiary OLX Group led a $120m round for the e-commerce app developers, which have agreed to merge, and will own 40% of the combined entity.
Naspers reaches Meesho in $125m round
Facebook provided $25m for the social commerce marketplace as part of a Naspers-led round that has been set to value it at up to $650m.
Analysis: Monitoring nine-figure corporate-backed rounds
Rounds above $100m tend to be raised by companies based in the US and China. Last year we saw a record number of corporate-backed rounds.
test reg

Login